ESMO Breast Cancer 2019

Oncology Meeting Resources

02 May - 04 May 2019, Berlin, Germany

ESMO Breast Cancer is an annual congress taking place for the first time on 2 - 4 May 2019 in Berlin, Germany. The congress is designed by the world’s foremost experts in breast cancer, authors with an outstanding publication track record.

Abtracts are open access. Presentations and webcasts from ESMO Breast Cancer 2019 are restricted to ESMO members according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity. Meeting programme   |  Future ESMO meetings

Direct access to special sessions:

Other ESMO resources on Breast Cancer





Format available

https://oncologypro.esmo.org/Meeting-Resour...-Breast-Cancer-2019/Welcome-and-introduction

Date: 02 May 2019
Presenter: Diana Lüftner
Resources: Presentation, Webcast
Topic: Breast Cancer

https://oncologypro.esmo.org/Meeting-Resour...ding-the-evidence-base-for-CDK4-6-inhibitors

Date: 02 May 2019
Presenter: Diana Lüftner
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...r-2019/The-advancing-role-of-PI3K-inhibitors

Date: 02 May 2019
Presenter: Peter Fasching
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...r-PIK3CA-mutations-An-interactive-discussion

Date: 02 May 2019
Presenter: Nicholas Turner
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...-Breast-Cancer-2019/Audience-question-answer

Date: 02 May 2019
Presenter: Diana Lüftner
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resources/ESMO-Breast-Cancer-2019/Opening-and-welcome

Date: 02 May 2019
Presenter: Sibylle Loibl
Resources: Presentation, Webcast
Topic: Breast Cancer

https://oncologypro.esmo.org/Meeting-Resources/ESMO-Breast-Cancer-2019/Award-Lecture

Date: 02 May 2019
Presenter: Jonas Bergh
Resources: Presentation, Webcast
Topics: Basic Scientific Principles, Breast Cancer, Basic Principles in the Management and Treatment (of cancer), Therapy

https://oncologypro.esmo.org/Meeting-Resour...itivity-to-PI3Ka-inhibitors-in-breast-cancer

BackgroundActivating mutations in PIK3CA, the gene coding for the catalytic subunit (p110α) of phosphoinositide-3-kinase (PI3K), are the most frequent oncogenic alterations in oestrogen receptor...

Date: 02 May 2019
Presenter: Neil Vasan
Resources: Abstract
Topics: Anticancer Agents, Personalised/Precision Medicine, Breast Cancer, Therapy

https://oncologypro.esmo.org/Meeting-Resour...ndomized-open-label-phase-II-study-SAKK-UNIC

BackgroundWe assumed that a strategy with dual blockade of T+P without chemotherapy followed by T-DM1 at progression might be similarly effective in terms of overall survival (OS), but less toxic...

Date: 02 May 2019
Presenter: Patrik Weder
Resources: Abstract, Presentation, Webcast
Topics: Anticancer Agents, Immunotherapy, Breast Cancer

https://oncologypro.esmo.org/Meeting-Resour...ncer-Updated-results-from-a-phase-I-II-trial

BackgroundHuman epidermal growth factor receptor 3 (HER3) is overexpressed in a variety of solid tumors, including breast cancer. U3-1402 is a HER3-targeted antibody drug conjugate with a novel peptide...

Date: 02 May 2019
Presenter: Kan Yonemori
Resources: Abstract, Presentation
Topics: Anticancer Agents, Breast Cancer